Systematic Financial Management LP Invests $1.14 Million in Humana Inc. (NYSE:HUM)

Systematic Financial Management LP bought a new position in Humana Inc. (NYSE:HUM) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 4,474 shares of the insurance provider’s stock, valued at approximately $1,135,000.

Several other hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. increased its position in Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the last quarter. Dodge & Cox increased its position in Humana by 106.7% in the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock worth $2,587,345,000 after purchasing an additional 5,264,045 shares during the last quarter. Pzena Investment Management LLC increased its position in Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock worth $915,736,000 after purchasing an additional 1,103,132 shares during the last quarter. Geode Capital Management LLC increased its position in Humana by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider’s stock worth $729,658,000 after purchasing an additional 63,562 shares during the last quarter. Finally, Invesco Ltd. increased its position in Humana by 29.8% in the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider’s stock worth $608,348,000 after purchasing an additional 550,692 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on HUM. Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 price target on shares of Humana in a research report on Thursday, May 1st. Raymond James upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a research report on Thursday, May 1st. Oppenheimer boosted their price objective on shares of Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a research report on Thursday, May 1st. Morgan Stanley cut their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Finally, Mizuho boosted their price objective on shares of Humana from $305.00 to $316.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. Seventeen equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus target price of $286.81.

Humana Trading Up 4.4%

NYSE HUM opened at $237.42 on Friday. The company’s 50-day moving average price is $262.94 and its 200-day moving average price is $269.49. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $28.65 billion, a PE ratio of 23.86, a PEG ratio of 2.05 and a beta of 0.49. Humana Inc. has a 12 month low of $212.45 and a 12 month high of $406.46.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts’ consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The company had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. During the same period in the prior year, the firm earned $7.23 earnings per share. The firm’s revenue for the quarter was up 8.4% compared to the same quarter last year. Equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.49%. The ex-dividend date is Friday, June 27th. Humana’s payout ratio is 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.